https://www.selleckchem.com/pr....oducts/ac-fltd-cmk.h
As investigator site audits have largely been conducted remotely during the COVID-19 pandemic, remote quality monitoring has gained some momentum. To further facilitate the conduct of remote quality assurance (QA) activities for clinical trials, we developed new quality indicators, building on a previously published statistical modeling methodology. We modeled the risk of having an audit or inspection finding using historical audits and inspections data from 2011 to 2019. We used logistic regression to model finding risk for 4 clini
Curtir
Comentario
Compartilhar
